Your session is about to expire
← Back to Search
Donepezil HCL for Alzheimer's Disease
Study Summary
This trial looks at how effective donepezil HCL is in detecting Alzheimer's in healthy adults over the age of 65.
- Alzheimer's Disease
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this study pioneering the exploration of a new medical treatment?
"Presently, 14 ongoing studies related to Donepezil HCL are occurring in 17 cities across 7 nations. The primary experiment involving this drug was conducted in 2013 by Dong-A Pharmaceutical Co., Ltd. and involved 210 patients before reaching the Phase 3 clinical trial stage of approval. Since then, an additional 18442 trials have been completed worldwide."
Is my medical history sufficient to qualify me for participation in this experiment?
"Eligibility criteria for this clinical trial is restricted to those aged 60-75 who have been diagnosed with Alzheimer's disease. A total of 90 patients need to be recruited in order for the study to take place."
Is this research effort currently taking on new participants?
"Unfortunately, the clinical trial described on clinicaltrials.gov is no longer in recruitment mode. This research project was initially posted on May 1st 2014 and last updated on May 16th 2022; however, 560 other studies are available for participation right now."
What is the participant capacity for this clinical experiment?
"This medical trial is not presently enrolling participants, though it was initially posted on May 1st 2014 and last updated 5/16/2022. In the case that you are looking for other studies, there exist currently 14 clinical trials involving Donepezil HCL recruiting patients as well as 546 related to Alzheimer's disease."
Does the participant eligibility criteria for this research include those below thirty years of age?
"Eligible candidates must be aged between 60 and 75. There are 23 trials targeting people younger than 18 whereas 549 studies focus on individuals above 65 years old."
Has Donepezil HCL been granted regulatory clearance by the FDA?
"Donepezil HCL has been approved and is thus rated a 3 on the safety scale. This Phase 4 trial provides further evidence to support this drug's efficacy."
For what medical conditions is Donepezil HCL typically prescribed?
"Donepezil HCL has been demonstrated to be effective in treating early-stage alzheimer's disease (AD), mild dementia of the Alzheimer's type, and vascular dementia."
Are there additional investigations that have utilized Donepezil HCL?
"Currently, there are 14 ongoing trials of Donepezil HCL with two in the late stage 3 classification. Most of these tests are located in Hallandale Beach, FL but there is a breadth of 26 clinical trial sites scattered across the country."
Share this study with friends
Copy Link
Messenger